183 related articles for article (PubMed ID: 35984750)
1. Adaptive cellular response of the substantia nigra dopaminergic neurons upon age-dependent iron accumulation.
Kwon K; Cho H; Lee S; Cho EJ; Yu W; Kok CYL; Je HS; Kim JI; Cho HJ; Kwon T
Aging Cell; 2022 Sep; 21(9):e13694. PubMed ID: 35984750
[TBL] [Abstract][Full Text] [Related]
2. S-Nitrosylation of Divalent Metal Transporter 1 Enhances Iron Uptake to Mediate Loss of Dopaminergic Neurons and Motoric Deficit.
Liu C; Zhang CW; Lo SQ; Ang ST; Chew KCM; Yu D; Chai BH; Tan B; Tsang F; Tai YK; Tan BWQ; Liang MC; Tan HT; Tang JY; Lai MKP; Chua JJE; Chung MCM; Khanna S; Lim KL; Soong TW
J Neurosci; 2018 Sep; 38(39):8364-8377. PubMed ID: 30104344
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
4. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
[TBL] [Abstract][Full Text] [Related]
5. Co-Expression of Nogo-A in Dopaminergic Neurons of the Human Substantia Nigra Pars Compacta Is Reduced in Parkinson's Disease.
Eyer GC; Di Santo S; Hewer E; Andereggen L; Seiler S; Widmer HR
Cells; 2021 Nov; 10(12):. PubMed ID: 34943877
[TBL] [Abstract][Full Text] [Related]
6. Pro-inflammatory cytokine-mediated ferroportin down-regulation contributes to the nigral iron accumulation in lipopolysaccharide-induced Parkinsonian models.
Zhang Z; Hou L; Song JL; Song N; Sun YJ; Lin X; Wang XL; Zhang FZ; Ge YL
Neuroscience; 2014 Jan; 257():20-30. PubMed ID: 24183966
[TBL] [Abstract][Full Text] [Related]
7. Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models.
Aimé P; Sun X; Zareen N; Rao A; Berman Z; Volpicelli-Daley L; Bernd P; Crary JF; Levy OA; Greene LA
J Neurosci; 2015 Jul; 35(30):10731-49. PubMed ID: 26224857
[TBL] [Abstract][Full Text] [Related]
8. Can mesenchymal stem cells reduce vulnerability of dopaminergic neurons in the substantia nigra to oxidative insult in individuals at risk to Parkinson's disease?
Datta I; Bhonde R
Cell Biol Int; 2012 Jul; 36(7):617-24. PubMed ID: 22417707
[TBL] [Abstract][Full Text] [Related]
9. Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.
Dragicevic E; Poetschke C; Duda J; Schlaudraff F; Lammel S; Schiemann J; Fauler M; Hetzel A; Watanabe M; Lujan R; Malenka RC; Striessnig J; Liss B
Brain; 2014 Aug; 137(Pt 8):2287-302. PubMed ID: 24934288
[TBL] [Abstract][Full Text] [Related]
10. Increased Ndfip1 in the substantia nigra of Parkinsonian brains is associated with elevated iron levels.
Howitt J; Gysbers AM; Ayton S; Carew-Jones F; Putz U; Finkelstein DI; Halliday GM; Tan SS
PLoS One; 2014; 9(1):e87119. PubMed ID: 24475238
[TBL] [Abstract][Full Text] [Related]
11. Isradipine attenuates MPTP-induced dopamine neuron degeneration by inhibiting up-regulation of L-type calcium channels and iron accumulation in the substantia nigra of mice.
Wang QM; Xu YY; Liu S; Ma ZG
Oncotarget; 2017 Jul; 8(29):47284-47295. PubMed ID: 28521299
[TBL] [Abstract][Full Text] [Related]
12. Time-dependent changes in iron levels and associated neuronal loss within the substantia nigra following lesions within the neostriatum/globus pallidus complex.
Sastry S; Arendash GW
Neuroscience; 1995 Aug; 67(3):649-66. PubMed ID: 7545796
[TBL] [Abstract][Full Text] [Related]
13. [Effect of electroacupuncture intervention on levels of SOD, GSH, GSH-Px, MDA, and apoptosis of dopaminergic neurons in substantia Nigra in rats with Parkinson's disease].
Li J; Wang LN; Xiao HL; Li X; Yang JJ
Zhen Ci Yan Jiu; 2014 Jun; 39(3):185-91. PubMed ID: 25069193
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress and Parkinson's disease.
Owen AD; Schapira AH; Jenner P; Marsden CD
Ann N Y Acad Sci; 1996 Jun; 786():217-23. PubMed ID: 8687021
[TBL] [Abstract][Full Text] [Related]
15. The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson's disease.
Biondetti E; Santin MD; Valabrègue R; Mangone G; Gaurav R; Pyatigorskaya N; Hutchison M; Yahia-Cherif L; Villain N; Habert MO; Arnulf I; Leu-Semenescu S; Dodet P; Vila M; Corvol JC; Vidailhet M; Lehéricy S
Brain; 2021 Nov; 144(10):3114-3125. PubMed ID: 33978742
[TBL] [Abstract][Full Text] [Related]
16. Effect of siRNA-induced silencing of cellular prion protein on tyrosine hydroxylase expression in the substantia nigra of a rat model of Parkinson's disease.
Wang X; Yang HA; Wang XN; Du YF
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173342
[TBL] [Abstract][Full Text] [Related]
17. [Morphochemical study of alpha-synuclein, iron and iron-containing proteins in the substantia nigra of the brain in Parkinson's disease].
Salkov VN; Khudoerkov RM; Voronkov DN; Sobolev VB
Arkh Patol; 2022; 84(2):13-19. PubMed ID: 35417944
[TBL] [Abstract][Full Text] [Related]
18. [Mechanism of α-lipoic acid promoting iron efflux in substantia nigra cells of Parkinson's disease rats].
Cai T; Wei C; Zhai S; Tai S; Zhang C; Jiao L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Jan; 34(1):35-40. PubMed ID: 29595455
[TBL] [Abstract][Full Text] [Related]
19. Quantitative proteomic profiling of the rat substantia nigra places glial fibrillary acidic protein at the hub of proteins dysregulated during aging: Implications for idiopathic Parkinson's disease.
Gómez-Gálvez Y; Fuller HR; Synowsky S; Shirran SL; Gates MA
J Neurosci Res; 2020 Jul; 98(7):1417-1432. PubMed ID: 32270889
[TBL] [Abstract][Full Text] [Related]
20. Neuronal vulnerability in Parkinson's disease.
Double KL
Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S52-4. PubMed ID: 22166454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
